Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 23.03 CNY 0.7% Market Closed
Market Cap: 7.1B CNY

Sirio Pharma Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sirio Pharma Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Operating Income
ÂĄ453.1m
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Operating Income
ÂĄ3.3B
CAGR 3-Years
-6%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Proya Cosmetics Co Ltd
SSE:603605
Operating Income
ÂĄ1.9B
CAGR 3-Years
31%
CAGR 5-Years
29%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Operating Income
ÂĄ826.7m
CAGR 3-Years
-24%
CAGR 5-Years
-7%
CAGR 10-Years
5%
S
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
Operating Income
ÂĄ933.9m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Operating Income
ÂĄ2.3B
CAGR 3-Years
36%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
7.1B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
25.68 CNY
Undervaluation 10%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Operating Income?
Operating Income
453.1m CNY

Based on the financial report for Sep 30, 2025, Sirio Pharma Co Ltd's Operating Income amounts to 453.1m CNY.

What is Sirio Pharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
14%

Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for Sirio Pharma Co Ltd have been 24% over the past three years , 14% over the past five years .

Back to Top